Golshayan D - Search Results

1

[Hypertension after kidney transplantation].

Schwotzer N, Wuerzner G, Golshayan D. Schwotzer N, et al. Among authors: golshayan d. Rev Med Suisse. 2021 Sep 15;17(750):1571-1574. Rev Med Suisse. 2021. PMID: 34528421 Review. French.

2

Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?

Golshayan D, Pascual M. Golshayan D, et al. Transpl Int. 2006 Nov;19(11):881-4. doi: 10.1111/j.1432-2277.2006.00391.x. Transpl Int. 2006. PMID: 17018122 Free article. No abstract available.

3

Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation.

Golshayan D, Pascual M. Golshayan D, et al. Transpl Immunol. 2008 Nov;20(1-2):21-8. doi: 10.1016/j.trim.2008.08.006. Epub 2008 Sep 4. Transpl Immunol. 2008. PMID: 18775494 Review.

4

Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

Golshayan D, Pascual M. Golshayan D, et al. Drugs. 2008;68(15):2113-30. doi: 10.2165/00003495-200868150-00004. Drugs. 2008. PMID: 18840003 Review.

5

[Rationale and clinical evidence for the use of rituximab in glomerular diseases].

Mani LY, Vogt B, Burnier M, Golshayan D. Mani LY, et al. Among authors: golshayan d. Rev Med Suisse. 2011 Apr 13;7(290):819-24. Rev Med Suisse. 2011. PMID: 21595313 Review. French.

6

Potential and limitations of regulatory T-cell therapy in solid organ transplantation.

Govender L, Pascual M, Golshayan D. Govender L, et al. Among authors: golshayan d. Expert Rev Clin Immunol. 2014 Sep;10(9):1197-212. doi: 10.1586/1744666X.2014.943191. Epub 2014 Jul 30. Expert Rev Clin Immunol. 2014. PMID: 25073810

7

Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation.

Salvadé I, Aubert V, Venetz JP, Golshayan D, Saouli AC, Matter M, Rotman S, Pantaleo G, Pascual M. Salvadé I, et al. Among authors: golshayan d. Hum Immunol. 2016 Jun;77(6):483-9. doi: 10.1016/j.humimm.2016.04.010. Epub 2016 Apr 13. Hum Immunol. 2016. PMID: 27085791

8

Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts.

Lorent M, Giral M, Pascual M, Koller MT, Steiger J, Trébern-Launay K, Legendre C, Kreis H, Mourad G, Garrigue V, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Golshayan D, Foucher Y. Lorent M, et al. Among authors: golshayan d. PLoS One. 2016 May 6;11(5):e0155278. doi: 10.1371/journal.pone.0155278. eCollection 2016. PLoS One. 2016. PMID: 27152510 Free PMC article.

9

ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study.

Mauthner O, Claes V, Walston J, Engberg S, Binet I, Dickenmann M, Golshayan D, Hadaya K, Huynh-Do U, Calciolari S, De Geest S; GERAS study consortium; For the Psychosocial Interest Group; Swiss Transplant Cohort Study (STCS). Mauthner O, et al. Among authors: golshayan d. J Adv Nurs. 2017 Mar;73(3):716-734. doi: 10.1111/jan.13179. Epub 2016 Nov 23. J Adv Nurs. 2017. PMID: 27731953

10

Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.

Muller YD, Ghaleb N, Rotman S, Vionnet J, Halfon M, Catana E, Golshayan D, Venetz JP, Aubert V, Pascual M. Muller YD, et al. Among authors: golshayan d. Transpl Int. 2018 Apr;31(4):451-455. doi: 10.1111/tri.13111. Epub 2018 Jan 30. Transpl Int. 2018. PMID: 29328536 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page